Advertisements

Stocking Stuffers

 

Ceapro Inc. (CZO:CA) Stock Quote

Detailed Quote for Ceapro Inc. (CZO:CA)
$ 0.37   -0.01 (-2.63%) Volume: 17k 3:59 PM EDT 26-Mar-2019
Today 5d 1m 3m 1y more
Last Price
0.37
Change $
0.01
Change %
2.63%
Tick
  
Bid
0.37
Bid Size
6,500
Ask
0.38
Ask Size
3,000
Open
0.365
High
0.37
Low
0.365
Prev Close
0.38
Last Trade
3:59
Volume
17k
52 Wk Hi
0.670000016
52 Wk Low
0.319999992
Market Cap
28.51m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
77,048,341
EPS (TTM)
-0.029999999
PE Ratio
N/A
Exchange
TSXV
News and Media for Ceapro Inc. (CZO:CA)
Sector News | Topic News
News for Ceapro Inc. (CZO:CA)
Mon, Mar 25, 2019
8:00 AM Ceapro Inc. Announces Issuance of Indian Patent Application for Enabling Pressurized Gas eXpanded (PGX) Technology - GlobeNewswire
Tue, Feb 26, 2019
8:00 AM Ceapro Inc. Announces Three Abstracts Selected for Oral Presentation at the 17th European Meeting on Supercritical Fluids (EMSF 2019) - GlobeNewswire
Mon, Jan 07, 2019
9:00 AM Ceapro Announces 2019 Management Team and Grant of Stock Options and Restricted Share Units - GlobeNewswire
Wed, Jan 02, 2019
8:00 AM Ceapro Inc. to Present at Biotech Showcase(TM) 2019 - GlobeNewswire
Wed, Dec 12, 2018
9:00 AM Ceapro Inc. Presents PGX Technology at the Society of Cosmetic Chemists' 72nd Annual Scientific Meeting and Technology Showcase - GlobeNewswire
Wed, Nov 21, 2018
9:00 AM Ceapro Inc. Reports 2018 Third Quarter and Nine-Month Financial Results and Operational Highlights - GlobeNewswire
Mon, Nov 19, 2018
8:00 AM Ceapro Inc. Announces Completion of Successful Audits by Major Customers - GlobeNewswire
Tue, Oct 23, 2018
8:05 AM Ceapro Inc. Receives the 2018 Award for Most Innovative Raw Material at Cosmetics 360 Salon in Paris - GlobeNewswire
Tue, Oct 09, 2018
8:00 AM Ceapro Inc. Receives Approval from Health Canada to Commence Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent - GlobeNewswire
Tue, Aug 28, 2018
9:00 AM Ceapro Inc. Reports 2018 Second Quarter and Six-Month Financial Results and Operational Highlights - GlobeNewswire
Mon, Aug 27, 2018
8:00 AM Ceapro Inc. Settles Judgements in AVAC Ltd. Actions - GlobeNewswire
Wed, Jun 27, 2018
8:30 AM Ceapro Inc. Announces Publication of Positive Data from Functional Beverage Formulation Study in Journal of Functional Foods - GlobeNewswire
Wed, Jun 13, 2018
7:00 AM Ceapro Announces Data from Avenanthramides Study Presented at the Nutrition 2018 Meeting - GlobeNewswire
Tue, Jun 05, 2018
9:00 AM Ceapro Announces Results of 2018 Shareholders' Meeting - GlobeNewswire
Tue, May 29, 2018
9:00 AM Ceapro Inc. Confirms Excellent Bioavailability of its New Water Soluble Chemical Complex Coenzyme Q10-Beta Glucan - GlobeNewswire
Thu, May 24, 2018
9:00 AM Ceapro Inc. to Provide a Corporate Update at Its Annual General and Special Meeting of Shareholders on May 29, 2018 - GlobeNewswire
Thu, May 17, 2018
9:00 AM Ceapro Inc. Reports 2018 First Quarter Results - GlobeNewswire
Wed, Apr 25, 2018
7:00 AM Ceapro Inc. Presents PGX Enabling Technology Case Study at the 12th International Symposium on Supercritical Fluids - GlobeNewswire
Mon, Apr 23, 2018
9:00 AM Ceapro Inc. Provides Corporate Update - GlobeNewswire
Fri, Apr 20, 2018
9:00 AM Ceapro Inc. Reports 2017 Financial Results - GlobeNewswire
More News for CZO:CA >>

Tags for Ceapro Inc.

Research stocks or mutual funds related to Ceapro Inc. by keywords or tags. Find companies that have a similar focus to CZO:CA. The keywords below have been associated to CZO:CA by either user submission or electronic means.

Pharmaceutical and Medicine Manufacturing (325410) Drugs Pharmaceutical and Medicine Industry (3741) Healthcare Common Stock